Shiota, Masaki http://orcid.org/0000-0002-3306-4858
Tanegashima, Tokiyoshi
Tatarano, Shuichi
Kamoto, Toshiyuki
Matsuyama, Hideyasu
Sakai, Hideki
Igawa, Tsukasa
Kamba, Tomomi
Fujimoto, Naohiro
Yokomizo, Akira
Naito, Seiji
Eto, Masatoshi
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (17K11145)
Japanese Urological Association
Takeda Science Foundation
Article History
Received: 4 July 2023
Revised: 2 February 2024
Accepted: 8 February 2024
First Online: 17 February 2024
Competing interests
: MS received honoraria from Janssen Pharmaceutical, AstraZeneca, Astellas Pharma, Sanofi, and Bayer and research funding support from Daiichi Sankyo. TK received research funding support from Janssen Pharmaceutical, Astellas Pharma, Shin Nippon Biomedical Laboratories, Ono Pharmaceutical, Bayer, Sanofi, and Takeda Pharmaceutical. HM received honoraria from Janssen Pharmaceutical, AstraZeneca, Astellas Pharma, Bayer, Chugai Pharmaceutical, and Merck and research funding support from Janssen Pharmaceutical, Takeda Pharmaceutical, and Kyowa Kirin. HS received honoraria from Takeda Pharmaceutical and Astellas Pharma. TI received honoraria from Janssen Pharmaceutical and Astellas Pharma. TK received honoraria from Takeda Pharmaceutical, AstraZeneca and Merck. AY received honoraria from Janssen Pharmaceutical and Astellas Pharma. ME received honoraria from Takeda Pharmaceutical, Janssen Pharmaceutical, AstraZeneca, and Astellas Pharma and research funding support from Astellas Pharma, Sanofi, and Takeda Pharmaceutical.
: The study protocol was approved by the institutional review board of each institute.
: All participants provided written informed consent.